{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T01:10:07Z","timestamp":1772932207590,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 81502202"],"award-info":[{"award-number":["Grant No. 81502202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["Grant No. 2020T130242"],"award-info":[{"award-number":["Grant No. 2020T130242"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01961-6","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T11:58:07Z","timestamp":1765367887000},"page":"1433-1448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated NDRG1 Expression Drives Oxaliplatin Chemoresistance in Bladder Cancer Cells by Promoting Homologous Recombination Repair and Inhibiting G2\/M Arrest"],"prefix":"10.1007","volume":"84","author":[{"given":"Yishuang","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huayu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunshu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3665-7835","authenticated-orcid":false,"given":"Si-si","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"1961_CR1","doi-asserted-by":"publisher","first-page":"1085476","DOI":"10.3389\/fimmu.2023.1085476","volume":"14","author":"Z Zhao","year":"2023","unstructured":"Zhao, Z., Liu, S., Sun, R., Zhu, W., Zhang, Y., Liu, T., Li, T., Jiang, N., Guo, H., & Yang, R. (2023). The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 Blockade in bladder cancer. Frontiers in Immunology, 14, 1085476.","journal-title":"Frontiers in Immunology"},{"key":"1961_CR2","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1200\/JCO.2010.29.3605","volume":"28","author":"A Sharma","year":"2010","unstructured":"Sharma, A., Dwary, A. D., Mohanti, B. K., Deo, S. V., Pal, S., Sreenivas, V., Raina, V., Shukla, N. K., Thulkar, S., Garg, P., & Chaudhary, S. P. (2010). Best supportive care compared with chemotherapy for unresectable gall bladder cancer: A randomized controlled study. Journal of Clinical Oncology, 28, 4581\u20134586.","journal-title":"Journal of Clinical Oncology"},{"key":"1961_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrc3088","volume":"11","author":"AJ Deans","year":"2011","unstructured":"Deans, A. J., & West, S. C. (2011). DNA interstrand crosslink repair and cancer. Nature Reviews Cancer, 11, 467\u2013480.","journal-title":"Nature Reviews Cancer"},{"key":"1961_CR4","doi-asserted-by":"publisher","first-page":"9537","DOI":"10.1093\/nar\/gky764","volume":"46","author":"J Slyskova","year":"2018","unstructured":"Slyskova, J., Sabatella, M., Ribeiro-Silva, C., Stok, C., Theil, A. F., Vermeulen, W., & Lans, H. (2018). Base and nucleotide excision repair facilitate resolution of platinum drugs-induced transcription blockage. Nucleic Acids Research, 46, 9537\u20139549.","journal-title":"Nucleic Acids Research"},{"key":"1961_CR5","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.1158\/1078-0432.CCR-20-1301","volume":"26","author":"MJ Pishvaian","year":"2020","unstructured":"Pishvaian, M. J., Wang, H., He, A. R., Hwang, J. J., Smaglo, B. G., Kim, S. S., Weinberg, B. A., Weiner, L. M., Marshall, J. L., & Brody, J. R. (2020). A phase I\/II study of veliparib (ABT-888) in combination with 5-Fluorouracil and oxaliplatin in patients with metastatic pancreatic cancer. Clinical Cancer Research, 26, 5092\u20135101.","journal-title":"Clinical Cancer Research"},{"key":"1961_CR6","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.3390\/cancers14184447","volume":"14","author":"A. Puccini","year":"2022","unstructured":"Puccini, A., Ponzano, M., Dalmasso, B., Vanni, I., Gandini, A., Puglisi, S., Borea, R., Cremante, M., Bruno, W., Andreotti, V., Allavena, E., Martelli, V., Catalano, F., Grassi, M., Iaia, M. L., Pirrone, C., Pastorino, A., Fornarini, G., Sciallero, S., Ghiorzo, P., & Pastorino, L. (2022). Clinical significance of germline pathogenic variants among 51 cancer predisposition genes in an unselected cohort of Italian pancreatic cancer patients. Cancers (Basel), 14, 4447.","journal-title":"Cancers (Basel)"},{"key":"1961_CR7","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1158\/0008-5472.CAN-22-2620","volume":"83","author":"A Petrelli","year":"2023","unstructured":"Petrelli, A., Rizzolio, S., Pietrantonio, F., Bellomo, S. E., Benelli, M., De Cecco, L., Romagnoli, D., Berrino, E., Orr\u00f9, C., Ribisi, S., Moya-Rull, D., Migliore, C., Conticelli, D., Maina, I. M., Puliga, E., Serra, V., Pellegrino, B., Llop-Guevara, A., Musolino, A., Siena, S., Sartore-Bianchi, A., Prisciandaro, M., Morano, F., Antista, M., Fumagalli, U., De Manzoni, G., Degiuli, M., Baiocchi, G. L., Amisano, M. F., Ferrero, A., Marchi\u00f2, C., Corso, S., & Giordano, S. (2023). BRCA2 germline mutations identify gastric cancers responsive to PARP inhibitors. Cancer Research, 83, 1699\u20131710.","journal-title":"Cancer Research"},{"key":"1961_CR8","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1158\/1078-0432.CCR-19-2409","volume":"26","author":"S Arena","year":"2020","unstructured":"Arena, S., Corti, G., Durinikova, E., Montone, M., Reilly, N. M., Russo, M., Lorenzato, A., Arcella, P., Lazzari, L., Rospo, G., Pagani, M., Cancelliere, C., Negrino, C., Isella, C., Bartolini, A., Cassingena, A., Amatu, A., Mauri, G., Sartore-Bianchi, A., Mittica, G., Medico, E., Marsoni, S., Linnebacher, M., Abrignani, S., Siena, S., Di Nicolantonio, F., & Bardelli, A. (2020). A subset of colorectal cancers with Cross-Sensitivity to Olaparib and oxaliplatin. Clinical Cancer Research, 26, 1372\u20131384.","journal-title":"Clinical Cancer Research"},{"key":"1961_CR9","doi-asserted-by":"publisher","first-page":"e65369","DOI":"10.1371\/journal.pone.0065369","volume":"8","author":"J. M. Park","year":"2013","unstructured":"Park, J. M., Huang, S., Tougeron, D., & Sinicrope, F. A. (2013). MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells. PLoS One, 8, e65369.","journal-title":"PLoS One"},{"key":"1961_CR10","doi-asserted-by":"publisher","first-page":"e161941","DOI":"10.1172\/JCI161941","volume":"134","author":"E. Kaur","year":"2024","unstructured":"Kaur, E., Agrawal, R., Arun, R., Madhavan, V., Srivastava, V., Kumar, D., Rath, P. P., Kumar, N., Vedagopuram, S., Pandey, N., Priya, S., Legembre, P., Gourinath, S., Bajaj, A., & Sengupta, S. (2024). Small molecules that disrupt RAD54-BLM interaction hamper tumor proliferation in colon cancer chemoresistance models. J Clin Invest, 134, e161941.","journal-title":"J Clin Invest"},{"key":"1961_CR11","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/s41416-022-01946-9","volume":"127","author":"CC Hsieh","year":"2022","unstructured":"Hsieh, C. C., Hsu, S. H., Lin, C. Y., Liaw, H. J., Li, T. W., Jiang, K. Y., Chiang, N. J., Chen, S. H., Lin, B. W., Chen, P. C., Chan, R. H., Lin, P. C., Yeh, Y. M., & Shen, C. H. (2022). CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer. British Journal of Cancer, 127, 1615\u20131628.","journal-title":"British Journal of Cancer"},{"key":"1961_CR12","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41419-022-05118-8","volume":"13","author":"W Huang","year":"2022","unstructured":"Huang, W., Han, Z., Sun, Z., Feng, H., Zhao, L., Yuan, Q., Chen, C., Yu, S., Hu, Y., Yu, J., Liu, H., Li, G., & Jiang, Y. (2022). PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through ATR\/CHK1 signaling in gastric cancer. Cell Death and Disease, 13, 658.","journal-title":"Cell Death and Disease"},{"key":"1961_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-genet-110410-132435","volume":"45","author":"LS Symington","year":"2011","unstructured":"Symington, L. S., & Gautier, J. (2011). Double-strand break end resection and repair pathway choice. Annual Review of Genetics, 45, 247\u2013271.","journal-title":"Annual Review of Genetics"},{"key":"1961_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","volume":"40","author":"A Ciccia","year":"2010","unstructured":"Ciccia, A., & Elledge, S. J. (2010). The DNA damage response: Making it safe to play with knives. Molecular Cell, 40, 179\u2013204.","journal-title":"Molecular Cell"},{"key":"1961_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/1574-6976.12066","volume":"38","author":"DP Mathiasen","year":"2014","unstructured":"Mathiasen, D. P., & Lisby, M. (2014). Cell cycle regulation of homologous recombination in Saccharomyces cerevisiae. Fems Microbiology Reviews, 38, 172\u2013184.","journal-title":"Fems Microbiology Reviews"},{"key":"1961_CR16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/cpr.12061","volume":"46","author":"O Vond\u00e1lov\u00e1 Blan\u00e1\u0159ov\u00e1","year":"2013","unstructured":"Vond\u00e1lov\u00e1 Blan\u00e1\u0159ov\u00e1, O., Jel\u00ednkov\u00e1, I., Hyr\u0161lov\u00e1 Vaculov\u00e1, A., Sova, P., Hofmanov\u00e1, J., & Kozub\u00edk, A. (2013). Higher anti-tumour efficacy of platinum(IV) complex LA-12 is associated with its ability to bypass M-phase entry block induced in oxaliplatin-treated human colon cancer cells. Cell Proliferation, 46, 665\u2013676.","journal-title":"Cell Proliferation"},{"key":"1961_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.canlet.2015.08.015","volume":"369","author":"Z Wang","year":"2015","unstructured":"Wang, Z., Lai, S. T., Ma, N. Y., Deng, Y., Liu, Y., Wei, D. P., Zhao, J. D., & Jiang, G. L. (2015). Radiosensitization of Metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage repair. Cancer Letters, 369, 192\u2013201.","journal-title":"Cancer Letters"},{"key":"1961_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/embor.2012.58","volume":"13","author":"J Falck","year":"2012","unstructured":"Falck, J., Forment, J. V., Coates, J., Mistrik, M., Lukas, J., Bartek, J., & Jackson, S. P. (2012). CDK targeting of NBS1 promotes DNA-end resection, replication restart and homologous recombination. Embo Reports, 13, 561\u2013568.","journal-title":"Embo Reports"},{"key":"1961_CR19","doi-asserted-by":"publisher","first-page":"e1003277","DOI":"10.1371\/journal.pgen.1003277","volume":"9","author":"H Wang","year":"2013","unstructured":"Wang, H., Shi, L. Z., Wong, C. C., Han, X., Hwang, P. Y., Truong, L. N., Zhu, Q., Shao, Z., Chen, D. J., Berns, M. W., Yates, J. R. 3rd, Chen, L., & Wu, X. (2013). The interaction of CtIP and Nbs1 connects CDK and ATM to regulate HR-mediated double-strand break repair. Plos Genetics, 9, e1003277.","journal-title":"Plos Genetics"},{"key":"1961_CR20","doi-asserted-by":"publisher","first-page":"eaay2669","DOI":"10.1126\/sciadv.aay2669","volume":"66","author":"G Lim","year":"2020","unstructured":"Lim, G., Chang, Y., & Huh, W. K. (2020). Phosphoregulation of Rad51\/Rad52 by CDK1 functions as a molecular switch for cell cycle-specific activation of homologous recombination. Science Advances, 6, eaay2669.","journal-title":"Science Advances"},{"key":"1961_CR21","doi-asserted-by":"publisher","first-page":"e79128","DOI":"10.7554\/eLife.79128","volume":"11","author":"A. Amar-Schwartz","year":"2022","unstructured":"Amar-Schwartz, A., Ben Hur, V., Jbara, A., Cohen, Y., Barnabas, G. D., Arbib, E., Siegfried, Z., Mashahreh, B., Hassouna, F., Shilo, A., Abu-Odeh, M., Berger, M., Wiener, R., Aqeilan, R., Geiger, T., & Karni, R. (2022). S6K1 phosphorylates Cdk1 and MSH6 to regulate DNA repair. Elife, 11, e79128.","journal-title":"Elife"},{"key":"1961_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.freeradbiomed.2019.05.020","volume":"157","author":"KC Park","year":"2020","unstructured":"Park, K. C., Paluncic, J., Kovacevic, Z., & Richardson, D. R. (2020). Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer. Free Radical Biology and Medicine, 157, 154\u2013175.","journal-title":"Free Radical Biology and Medicine"},{"key":"1961_CR23","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1038\/s41598-019-41660-w","volume":"9","author":"A Li","year":"2019","unstructured":"Li, A., Zhu, X., Wang, C., Yang, S., Qiao, Y., Qiao, R., & Zhang, J. (2019). Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer. Scientific Reports, 9, 5166.","journal-title":"Scientific Reports"},{"key":"1961_CR24","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.7150\/ijbs.69373","volume":"18","author":"L Ren","year":"2022","unstructured":"Ren, L., Jiang, M., Xue, D., Wang, H., Lu, Z., Ding, L., Xie, H., Wang, R., Luo, W., Xu, L., Wang, M., Yu, S., Cheng, S., Xia, L., Yu, H., Huang, P., Xu, N., & Li, G. (2022). Nitroxoline suppresses metastasis in bladder cancer via EGR1\/circNDRG1\/miR-520 h\/smad7\/EMT signaling pathway. International Journal of Biological Sciences, 18, 5207\u20135220.","journal-title":"International Journal of Biological Sciences"},{"key":"1961_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canlet.2016.02.056","volume":"375","author":"KH Tsui","year":"2016","unstructured":"Tsui, K. H., Lin, Y. H., Chung, L. C., Chuang, S. T., Feng, T. H., Chiang, K. C., Chang, P. L., Yeh, C. J., & Juang, H. H. (2016). Prostate-derived Ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells. Cancer Letters, 375, 142\u2013151.","journal-title":"Cancer Letters"},{"key":"1961_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.bj.2021.10.006","volume":"45","author":"CP Hou","year":"2022","unstructured":"Hou, C. P., Tsui, K. H., Chang, K. S., Sung, H. C., Hsu, S. Y., Lin, Y. H., Yang, P. S., Chen, C. L., Feng, T. H., & Juang, H. H. (2022). Caffeic acid phenethyl ester inhibits the growth of bladder carcinoma cells by upregulating growth differentiation factor 15. Biomed J, 45, 763\u2013775.","journal-title":"Biomed J"},{"key":"1961_CR27","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3390\/ijms20040980","volume":"20","author":"K. H. Tsui","year":"2019","unstructured":"Tsui, K. H., Hou, C. P., Chang, K. S., Lin, Y. H., Feng, T. H., Chen, C. C., Shin, Y. S., & Juang, H. H. (2019). Metallothionein 3 is a Hypoxia-Upregulated oncogene enhancing cell invasion and tumorigenesis in human bladder carcinoma cells. International Journal of Molecular Sciences, 20, 980.","journal-title":"International Journal of Molecular Sciences"},{"key":"1961_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12885-020-6652-7","volume":"20","author":"S Ueki","year":"2020","unstructured":"Ueki, S., Fujishima, F., Kumagai, T., Ishida, H., Okamoto, H., Takaya, K., Sato, C., Taniyma, Y., Kamei, T., & Sasano, H. (2020). GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: Their correlation with therapeutic outcome of neoadjuvant chemotherapy. Bmc Cancer, 20, 161.","journal-title":"Bmc Cancer"},{"key":"1961_CR29","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.7150\/ijms.28055","volume":"15","author":"A Du","year":"2018","unstructured":"Du, A., Jiang, Y., & Fan, C. (2018). NDRG1 downregulates ATF3 and inhibits Cisplatin-Induced cytotoxicity in lung cancer A549 cells. International Journal of Medical Sciences, 15, 1502\u20131507.","journal-title":"International Journal of Medical Sciences"},{"key":"1961_CR30","first-page":"1155","volume":"45","author":"G Chen","year":"2022","unstructured":"Chen, G., Gong, T., Wang, Z., Wang, Z., Lin, X., Chen, S., Sun, C., Zhao, W., Kong, Y., Ai, H., Yang, H., Liu, Y., Wu, F., Kang, J., Zhao, S., Xiao, X., Sun, J., He, A., & Li, Z. (2022). Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution. Cell Oncol (Dordr), 45, 1155\u20131167.","journal-title":"Cell Oncol (Dordr)"},{"key":"1961_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1385\/MO:19:4:261","volume":"19","author":"H Ehrsson","year":"2002","unstructured":"Ehrsson, H., Wallin, I., & Yachnin, J. (2002). Pharmacokinetics of oxaliplatin in humans. Medical Oncology, 19, 261\u2013265.","journal-title":"Medical Oncology"},{"key":"1961_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3892\/ol.2021.13134","volume":"23","author":"J Ma","year":"2022","unstructured":"Ma, J., Chen, X., Zhu, X., Pan, Z., Hao, W., Li, D., Zheng, Q., & Tang, X. (2022). Luteolin potentiates low-dose oxaliplatin-induced inhibitory effects on cell proliferation in gastric cancer by inducing G(2)\/M cell cycle arrest and apoptosis. Oncol Lett, 23, 16.","journal-title":"Oncol Lett"},{"key":"1961_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bcp.2008.04.007","volume":"76","author":"P Noordhuis","year":"2008","unstructured":"Noordhuis, P., Laan, A. C., van de Born, K., Losekoot, N., Kathmann, I., & Peters, G. J. (2008). Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines. Biochemical Pharmacology, 76, 53\u201361.","journal-title":"Biochemical Pharmacology"},{"key":"1961_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13046-020-01811-8","volume":"40","author":"PP Vitiello","year":"2021","unstructured":"Vitiello, P. P., Martini, G., Mele, L., Giunta, E. F., De Falco, V., Ciardiello, D., Belli, V., Cardone, C., Matrone, N., Poliero, L., Tirino, V., Napolitano, S., Della Corte, C., Selvaggi, F., Papaccio, G., Troiani, T., Morgillo, F., Desiderio, V., Ciardiello, F., & Martinelli, E. (2021). Vulnerability to low-dose combination of Irinotecan and niraparib in ATM-mutated colorectal cancer. Journal of Experimental & Clinical Cancer Research : Cr, 40, 15.","journal-title":"Journal of Experimental &amp; Clinical Cancer Research : Cr"},{"key":"1961_CR35","doi-asserted-by":"publisher","first-page":"e0146256","DOI":"10.1371\/journal.pone.0146256","volume":"111","author":"S Wang","year":"2016","unstructured":"Wang, S., Zhang, H., Scharadin, T. M., Zimmermann, M., Hu, B., Pan, A. W., Vinall, R., Lin, T. Y., Cimino, G., Chain, P., Vuyisich, M., Gleasner, C., McMurry, K., Malfatti, M., Turteltaub, K., de White, V., Pan, R., & Henderson, C. X., P.T (2016). Molecular dissection of induced platinum resistance through functional and gene expression analysis in a cell culture model of bladder cancer. PLoS One, 111, e0146256.","journal-title":"PLoS One"},{"key":"1961_CR36","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1349-7006.2010.01784.x","volume":"102","author":"E Kashiwagi","year":"2011","unstructured":"Kashiwagi, E., Izumi, H., Yasuniwa, Y., Baba, R., Doi, Y., Kidani, A., Arao, T., Nishio, K., Naito, S., & Kohno, K. (2011). Enhanced expression of nuclear factor I\/B in oxaliplatin-resistant human cancer cell lines. Cancer Science, 102, 382\u2013386.","journal-title":"Cancer Science"},{"key":"1961_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0304-3835(97)00255-3","volume":"119","author":"M Abu-Hadid","year":"1997","unstructured":"Abu-Hadid, M., Wilkes, J. D., Elakawi, Z., Pendyala, L., & Perez, R. P. (1997). Relationship between heat shock protein 60 (HSP60) mRNA expression and resistance to platinum analogues in human ovarian and bladder carcinoma cell lines. Cancer Letters, 119, 63\u201370.","journal-title":"Cancer Letters"},{"key":"1961_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3892\/ijo.2023.5568","volume":"63","author":"T. Morinaka","year":"2023","unstructured":"Morinaka, T., Sakai, N., Takayashiki, T., Kuboki, S., Takano, S., Ohira, G., Matsubara, H., & Ohtsuka, M. (2023). RYBP contributes to improved prognosis in colorectal cancer via regulation of cell cycle, apoptosis and oxaliplatin sensitivity. International Journal of Oncology, 63, 120.","journal-title":"International Journal of Oncology"},{"key":"1961_CR39","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00280-010-1428-4","volume":"67","author":"M Kalimutho","year":"2011","unstructured":"Kalimutho, M., Minutolo, A., Grelli, S., Formosa, A., Sancesario, G., Valentini, A., Federici, G., & Bernardini, S. (2011). Satraplatin (JM-216) mediates G2\/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance. Cancer Chemotherapy and Pharmacology, 67, 1299\u20131312.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"1961_CR40","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.bcp.2013.10.012","volume":"86","author":"VR Menon","year":"2013","unstructured":"Menon, V. R., Peterson, E. J., Valerie, K., Farrell, N. P., & Povirk, L. F. (2013). Ligand modulation of a dinuclear platinum compound leads to mechanistic differences in cell cycle progression and arrest. Biochemical Pharmacology, 86, 1708\u20131720.","journal-title":"Biochemical Pharmacology"},{"key":"1961_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.canlet.2011.05.034","volume":"310","author":"J Akiba","year":"2011","unstructured":"Akiba, J., Murakami, Y., Noda, M., Watari, K., Ogasawara, S., Yoshida, T., Kawahara, A., Sanada, S., Yasumoto, M., Yamaguchi, R., Kage, M., Kuwano, M., Ono, M., & Yano, H. (2011). N-myc downstream regulated gene1\/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0\/G1 phase. Cancer Letters, 310, 25\u201334.","journal-title":"Cancer Letters"},{"key":"1961_CR42","doi-asserted-by":"publisher","first-page":"e2201605","DOI":"10.1002\/smtd.202201605","volume":"7","author":"J Mircetic","year":"2023","unstructured":"Mircetic, J., Camg\u00f6z, A., Abohawya, M., Ding, L., Dietzel, J., Tobar, S. G., Paszkowski-Rogacz, M., Seidlitz, T., Schm\u00e4che, T., Mehnert, M. C., Sidorova, O., Weitz, J., Buchholz, F., & Stange, D. E. (2023). CRISPR\/Cas9 screen in gastric cancer Patient-Derived organoids reveals KDM1A-NDRG1 axis as a targetable vulnerability. Small Methods, 7, e2201605.","journal-title":"Small Methods"},{"key":"1961_CR43","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/carcin\/bgt401","volume":"35","author":"WJ Lu","year":"2014","unstructured":"Lu, W. J., Chua, M. S., & So, S. K. (2014). Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma. Carcinogenesis, 35, 915\u2013922.","journal-title":"Carcinogenesis"},{"key":"1961_CR44","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/carcin\/bgr046","volume":"32","author":"Z Kovacevic","year":"2011","unstructured":"Kovacevic, Z., Sivagurunathan, S., Mangs, H., Chikhani, S., Zhang, D., & Richardson, D. R. (2011). The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms. Carcinogenesis, 32, 732\u2013740.","journal-title":"Carcinogenesis"},{"key":"1961_CR45","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1158\/0008-5472.CAN-19-0438","volume":"80","author":"H Ito","year":"2020","unstructured":"Ito, H., Watari, K., Shibata, T., Miyamoto, T., Murakami, Y., Nakahara, Y., Izumi, H., Wakimoto, H., Kuwano, M., Abe, T., & Ono, M. (2020). Bidirectional regulation between NDRG1 and GSK3\u03b2 controls tumor growth and is targeted by differentiation inducing Factor-1 in glioblastoma. Cancer Research, 80, 234\u2013248.","journal-title":"Cancer Research"},{"key":"1961_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2018.11.019","volume":"443","author":"B Xie","year":"2019","unstructured":"Xie, B., Wang, S., Jiang, N., & Li, J. J. (2019). Cyclin B1\/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance. Cancer Letters, 443, 56\u201366.","journal-title":"Cancer Letters"},{"key":"1961_CR47","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/emboj.2011.27","volume":"30","author":"A Shibata","year":"2011","unstructured":"Shibata, A., Conrad, S., Birraux, J., Geuting, V., Barton, O., Ismail, A., Kakarougkas, A., Meek, K., Taucher-Scholz, G., L\u00f6brich, M., & Jeggo, P. A. (2011). Factors determining DNA double-strand break repair pathway choice in G2 phase. Embo J, 30, 1079\u20131092.","journal-title":"Embo J"},{"key":"1961_CR48","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1146\/annurev-biochem-060614-034335","volume":"84","author":"P T.T Paull","year":"2015","unstructured":"Paull, P. T.T. (2015). Mechanisms of ATM activation. Annual Review of Biochemistry, 84, 711\u2013738.","journal-title":"Annual Review of Biochemistry"},{"key":"1961_CR49","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3390\/biom5031990","volume":"5","author":"Y Saito","year":"2015","unstructured":"Saito, Y., & Komatsu, K. (2015). Functional role of NBS1 in radiation damage response and translesion. DNA Synthesis Biomolecules, 5, 1990\u20132002.","journal-title":"DNA Synthesis Biomolecules"},{"key":"1961_CR50","doi-asserted-by":"publisher","first-page":"188716","DOI":"10.1016\/j.bbcan.2022.188716","volume":"1877","author":"M Kciuk","year":"2022","unstructured":"Kciuk, M., Gieleci\u0144ska, A., Mujwar, S., Mojzych, M., & Kontek, R. (2022). Cyclin-dependent kinases in DNA damage response. Biochimica Et Biophysica Acta - Reviews on Cancer, 1877, 188716.","journal-title":"Biochimica Et Biophysica Acta - Reviews on Cancer"},{"key":"1961_CR51","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41580-020-0218-z","volume":"21","author":"M Tarsounas","year":"2020","unstructured":"Tarsounas, M., & Sung, P. (2020). The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication. Nature Reviews Molecular Cell Biology, 21, 284\u2013299.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"1961_CR52","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.chembiol.2018.02.012","volume":"25","author":"J Periasamy","year":"2018","unstructured":"Periasamy, J., Kurdekar, V., Jasti, S., Nijaguna, M. B., Boggaram, S., Hurakadli, M. A., Raina, D., Kurup, L. M., Chintha, C., Manjunath, K., Goyal, A., Sadasivam, G., Bharatham, K., Padigaru, M., Potluri, V., & Venkitaraman, A. R. (2018). Targeting phosphopeptide recognition by the human BRCA1 tandem BRCT domain to interrupt BRCA1-Dependent signaling. Cell Chem Biol, 25, 677\u2013690e12.","journal-title":"Cell Chem Biol"},{"key":"1961_CR53","doi-asserted-by":"publisher","first-page":"7347","DOI":"10.1093\/nar\/gks353","volume":"40","author":"B Budke","year":"2012","unstructured":"Budke, B., Logan, H. L., Kalin, J. H., Zelivianskaia, A. S., Cameron McGuire, W., Miller, L. L., Stark, J. M., Kozikowski, A. P., Bishop, D. K., & Connell, P. P. (2012). RI-1: A chemical inhibitor of RAD51 that disrupts homologous recombination in human cells. Nucleic Acids Research, 40, 7347\u20137357.","journal-title":"Nucleic Acids Research"},{"key":"1961_CR54","doi-asserted-by":"publisher","first-page":"15848","DOI":"10.1073\/pnas.0808046105","volume":"105","author":"K Jayathilaka","year":"2008","unstructured":"Jayathilaka, K., Sheridan, S. D., Bold, T. D., Bochenska, K., Logan, H. L., Weichselbaum, R. R., Bishop, D. K., & Connell, P. P. (2008). A chemical compound that stimulates the human homologous recombination protein RAD51. Proc Natl Acad Sci U S A, 105, 15848\u201315853.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1961_CR55","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/jnci\/djy085","volume":"110","author":"MM Hoppe","year":"2018","unstructured":"Hoppe, M. M., Sundar, R., Tan, D. S. P., & Jeyasekharan, A. D. (2018). Biomarkers for homologous recombination deficiency in cancer. Journal of the National Cancer Institute, 110, 704\u2013713.","journal-title":"Journal of the National Cancer Institute"},{"key":"1961_CR56","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1158\/1535-7163.MCT-20-0992","volume":"20","author":"N Goel","year":"2021","unstructured":"Goel, N., Foxall, M. E., Scalise, C. B., Wall, J. A., & Arend, R. C. (2021). Strategies in overcoming homologous recombination proficiency and PARP inhibitor resistance. Molecular Cancer Therapeutics, 20, 1542\u20131549.","journal-title":"Molecular Cancer Therapeutics"},{"key":"1961_CR57","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.21873\/anticanres.16754","volume":"43","author":"C Kim","year":"2023","unstructured":"Kim, C., Kim, D., Lee, D. S., Lee, S., Yoo, C., & Kim, K. P. (2023). PARP inhibitor sensitizes BRCA-mutant pancreatic cancer to oxaliplatin by suppressing the CDK1\/BRCA1 axis. Anticancer Research, 43, 5523\u20135534.","journal-title":"Anticancer Research"},{"key":"1961_CR58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ygyno.2022.11.006","volume":"168","author":"N Yanaihara","year":"2023","unstructured":"Yanaihara, N., Yoshino, Y., Noguchi, D., Tabata, J., Takenaka, M., Iida, Y., Saito, M., Yanagida, S., Iwamoto, M., Kiyokawa, T., Chiba, N., & Okamoto, A. (2023). Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1\/BRCA1 pathway. Gynecologic Oncology, 168, 83\u201391.","journal-title":"Gynecologic Oncology"},{"key":"1961_CR59","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ptr.5257","volume":"29","author":"LD Guo","year":"2015","unstructured":"Guo, L. D., Shen, Y. Q., Zhao, X. H., Guo, L. J., Yu, Z. J., Wang, D., Liu, L. M., & Liu, J. Z. (2015). Curcumin combined with oxaliplatin effectively suppress colorectal carcinoma in vivo through inducing apoptosis. Phytotherapy Research: Ptr, 29, 357\u2013365.","journal-title":"Phytotherapy Research: Ptr"},{"key":"1961_CR60","doi-asserted-by":"publisher","first-page":"104741","DOI":"10.1016\/j.bioorg.2021.104741","volume":"110","author":"M Wang","year":"2021","unstructured":"Wang, M., Liu, Z., Huang, X., Chen, Y., Wang, Y., Kong, J., Yang, Y., Yu, C., Li, J., Wang, X., & Wang, H. (2021). Dual-target platinum(IV) complexes exhibit antiproliferative activity through DNA damage and induce ER-stress-mediated apoptosis in A549 cells. Bioorganic Chemistry, 110, 104741.","journal-title":"Bioorganic Chemistry"},{"key":"1961_CR61","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s10495-013-0883-x","volume":"18","author":"CR Timme","year":"2013","unstructured":"Timme, C. R., Gruidl, M., & Yeatman, T. J. (2013). Gamma-secretase Inhibition attenuates oxaliplatin-induced apoptosis through increased Mcl-1 and\/or Bcl-xL in human colon cancer cells. Apoptosis, 18, 1163\u20131174.","journal-title":"Apoptosis"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01961-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01961-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01961-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T06:03:13Z","timestamp":1772863393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01961-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1961"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01961-6","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"24 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}